DARZALEX ® (daratumumab) Combination Regimen Significantly Improved Outcomes for Newly Diagnosed Multiple Myeloma Patients who are Transplant Ineligible

Source: Johnson and Johnson - Category: Pharmaceuticals Source Type: news